Shopping Cart
- Remove All
Your shopping cart is currently empty
Cdc7-IN-20 (EP-05) is an orally bioavailable and selective inhibitor of Cdc7, with IC50 and Ki values of 0.93 nM and 0.11 nM, respectively. It exhibits antitumor activity.

| Description | Cdc7-IN-20 (EP-05) is an orally bioavailable and selective inhibitor of Cdc7, with IC50 and Ki values of 0.93 nM and 0.11 nM, respectively. It exhibits antitumor activity. |
| In vitro | Cdc7-IN-20 at concentrations of 0.5, 1, and 2 μM for 24 hours can inhibit the proliferation of COLO 205 cells. |
| In vivo | Cdc7-IN-20, administered orally at doses of 2, 4, and 8 mg/kg for 3 consecutive days, demonstrates antitumor activity in a COLO 205 xenograft mouse model. |
| Formula | C15H16N4OS |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.